Skip to main content
. 2020 Feb 9;10(2):e034629. doi: 10.1136/bmjopen-2019-034629

Figure 2.

Figure 2

Schema for the enable phase I dose escalation study. Second attempt at cell harvest and WZTL-002 production may be considered at discretion of TMC. Six-month PET scan if first PET scan post WZTL-002 treatment shows partial response. Long-term follow-up through bone marrow transplant clinic and Cellular Therapies Registry enrolment. FluCy, fludarabine and cyclophosphamide IV; PET, positron emission tomography; TMC, trial management committee.